🟢 Rua Bioscience is trading 11.11% up today after commencing direct distribution to improve margins

Rua Bioscience is trading at NZD 0.04, up +11.11%, after commencing direct distribution from Tairāwhiti in New Zealand.

• The company announced the move on September 7, 2026, shifting to a direct-to-market model.
• Management said the change should improve margins while retaining economic activity in the region.
• The move follows approval of five new medicinal cannabis products, supporting the company’s domestic sales strategy.